CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- S-1 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3/A Insider 3/A
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $1.39 ($13,900)
- 4 Open-market buy Director bought 20,000 shares at $1.67 ($33,398)
- 4 Grant or award CEO and Chairman acquired 25,000 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- 4 Conversion Director acquired 50,000 shares (conversion)
- 4 Grant or award Chief Financial Officer acquired 50,000 shares (grant or award)
- 4 Conversion Director acquired 514,792 shares (conversion)
Page 12 of 14 · 277 filings